(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

DXTM

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

DXTM

ST13

US500000090654311

Classe

5, 9, 10

Pedido

90654311

Registro

7537856

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

45

Atualização mais recente

15/10/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 9, 10

Data de depósito

19/04/2021

Data de registro

15/10/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

15/10/2024

Última transação

15/10/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

22/08/2024

Primeiro uso no comércio

22/08/2024

Código do desenho

4

Tipo de titular

03

Localização do titular

Mississauga, Ontario, CA

Examinador

LEE, JANET H

Unidade examinadora

N60

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Microbix Biosystems Inc.

Representantes

Richard M. LaBarge MARSHALL, GERSTEIN & BORUN LLP

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Liquid medium solutions used to preserve and transport a patient's test specimen for medical and clinical use; chemically treated reagent paper for clinical medical purposes; chemically treated paper for preserving diagnosticbiologicalchemical samples; viral transport media for use in collectingtransportingmaintainingstoringtestingdiagnosing infections withresearching virusesbacteriaparasitesanimal-derived biological matter for medical research or for medical diagnostic purposes; sample containers that include a culture medium for transport and conservation of viral samples for medical research and diagnostic use

Classe 9

Testing sample collection equipment for medical researchtransport media and disposable test tubes for use in clinical and industrial diagnostic testingcollectiontransportmaintenancestorage and research of virusesbacteriaparasitesanimal-derived biological matter; disposable test tubes for use in diagnostic testingcollectiontransportmaintenancestorageresearch of viruseschlamydiamycoplasmaand/or ureaplasma; devices for collectingconservingtransporting biologicalchemical or diagnostic samplestesting sample collection equipmentwipes for use in clinical and industrial diagnostic testingnot for medical or medical diagnostic purposes; disposable devices for collection and conservation of biologicalchemical or diagnostic samplesdisposable plastic vessels for cell culturing for laboratory use; small sample containers for transport and conservation of biologicalchemical and diagnostic samples; manual laboratory toolstest tubes and incubators

Classe 10

Testing sample collection equipment for medical diagnostic purposestransport media and disposable test tubes for use in medical diagnostic testingcollectiontransportmaintenancestorage and research of virusesbacteriaparasitesanimal-derived biological matter; Devices for collectingconservingtransporting biologicalchemical or diagnostic samplestesting sample collection equipmentwipes for use in diagnostic testing for medical purposes or for medical diagnostic purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

45 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

15/10/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

15/10/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/09/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/09/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/09/2024

IUAF

USE AMENDMENT FILED

28/08/2024

EISU

TEAS STATEMENT OF USE RECEIVED

28/08/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

28/08/2024

EX3G

SOU EXTENSION 3 GRANTED

28/08/2024

EXT3

SOU EXTENSION 3 FILED

28/08/2024

EEXT

SOU TEAS EXTENSION RECEIVED

28/08/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/03/2024

EX2G

SOU EXTENSION 2 GRANTED

29/02/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

29/02/2024

EXT2

SOU EXTENSION 2 FILED

14/02/2024

EEXT

SOU TEAS EXTENSION RECEIVED

14/02/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

24/08/2023

EX1G

SOU EXTENSION 1 GRANTED

22/08/2023

EXT1

SOU EXTENSION 1 FILED

22/08/2023

EEXT

SOU TEAS EXTENSION RECEIVED

22/08/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

28/02/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/01/2023

PUBO

PUBLISHED FOR OPPOSITION

03/01/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

14/12/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

29/11/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

29/11/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

29/11/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

29/11/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

29/11/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/11/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/11/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/11/2022

DOCK

ASSIGNED TO EXAMINER

26/10/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/06/2022

GNRT

NON-FINAL ACTION E-MAILED

10/06/2022

CNRT

NON-FINAL ACTION WRITTEN

10/06/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/05/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/05/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/05/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

14/12/2021

GNRT

NON-FINAL ACTION E-MAILED

14/12/2021

CNRT

NON-FINAL ACTION WRITTEN

14/12/2021

DOCK

ASSIGNED TO EXAMINER

13/12/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

26/07/2021

NWAP

NEW APPLICATION ENTERED

22/04/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace DXTM ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.